Document is current
Any future updates will be listed below
-
Authors
Nagai, Shigenori E. https://orcid.org/0000-0003-2887-6066
Hattori, Masaya
Yoshinami, Tetsuhiro
Masuda, Hiroko
Okamura, Takuho
Watanabe, Kenichi
Nakayama, Takahiro
Tsuneizumi, Michiko
Takabatake, Daisuke
Harao, Michiko
Yoshino, Hiroshi
Mori, Natsuko
Yasojima, Hiroyuki
Oshiro, Chiya
Iwase, Madoka
Yamaguchi, Miki
Sangai, Takafumi
Sasada, Shinsuke
Ishida, Takanori
Futamura, Manabu
Muramatsu, Yasuaki
Kosaka, Nobuyoshi https://orcid.org/0000-0001-5571-261X
Masuda, Norikazu https://orcid.org/0000-0002-7302-0278
-
Funding
Funding for this research was provided by:
Pfizer Japan
- License Information
-
More Information
Article History
Received: 3 December 2024
Accepted: 3 March 2025
First Online: 5 April 2025
Declarations
:
: SN reports honoraria from AstraZeneca, Daiichi-Sankyo, Eisai, Eli Lilly, MSD, Taiho, Chugai, and Pfizer. MaHa reports honoraria from Eli Lilly and Pfizer.TY reports honoraria from AstraZeneca, Chugai, Eisai, Eli Lilly, MSD, and Pfizer. HiMa reports honoraria from Eli Lilly, Chugai, and Pfizer. KW reports honoraria from AstraZeneca, Daiichi-Sankyo, Eisai, Shionogi, Kyowa-Kirin, Nippon-Kayaku, Novartis, Eli Lilly, Taiho, Chugai, and Pfizer. TN reports honoraria from AstraZeneca, Daiichi-Sankyo, Eisai, Novartis, Eli Lilly, Taiho, Chugai, and Pfizer. TS reports honoraria from Chugai, Novartis, MSD, Taiho, Eisai, Maruho, PDRadiopahrma, Nippon-Kayaku, Kyowa-Kirin, AstraZeneca, Eli Lilly, Daiichi -Sankyo and Pfizer; and institutional support from Taiho. MY reports honoraria from AstraZeneca, Daiichi-Sankyo, Eisai, Kyowa-Kirin, Nippon-Kayaku, Eli Lilly, Taiho, Chugai, and Pfizer. TI reports honoraria from Chugai, and Pfizer. MF reports honoraria from Chugai, Taiho, Eisai, Nippon-Kayaku, Eli Lilly, and Daiichi -Sankyo. NK is employees of Pfizer Inc. is stockholders in Pfizer Inc. YM is employees of Pfizer Inc. is stockholders in Pfizer Inc. NM reports honoraria from Chugai, Pfizer, AstraZeneca, Eli Lilly, and Daiichi -Sankyo; and institutional support from Chugai, Eli Lilly, AstraZeneca, Pfizer, Daiichi-Sankyo, MSD, Eisai, Novartis, Sanofi, KyowaKirin, and Nippon Kayaku. TO, MT, DT, MiHa, HY, NaMo, HY, CO, MI, and SS have no disclosures.
